Consumer Health

This report examines inflation levels and drivers globally and in key countries. Global inflation is moderating, although divergence among the key economies increases. Higher volatility in the energy markets and disruption of agricultural commodities…

In the upcoming years, consumers and businesses face an array of challenges, with income inequality, mass migration and rising uncertainty about another crisis being among the major ones. Nevertheless, within this lie untapped opportunities. This…

Consumer Types can be a powerful tool to help companies better understand and appeal to their target markets. Consumers are grouped based on shared traits and preferences, companies can better develop products and marketing campaigns that resonate…

Rising inflation has caused consumers to be increasingly stressed in 2023, with rising price points and ongoing economic uncertainty negatively impacting lives. This ongoing uncertainty has led to an increase in physical discomforts; often in the…

Analgesics is recording another strong year of current value growth in 2023, albeit at a slower rate than in 2022. Growth is particularly dynamic in the paediatric segment, especially for acetaminophen and ibuprofen, driven by the outbreak of…

In 2023, increased socialising and the return to post-pandemic habits support the growth of several OTC categories. However, high inflation and a fluctuating exchange rate continue to create uncertainty. Inflation in Costa Rica was 8.27% in 2022, the…

In 2023, consumer health products in Jordan are witnessing notable changes driven by a combination of factors. The industry has experienced a decline from its peaks in 2020 and 2021 when Jordanians rushed to purchase OTC products like analgesics and…

Consumer health continues to experience high retail current value growth in 2023, albeit at a slower rate than 2022. Higher costs of materials, ingredients and services are naturally leading to strong price increases in 2023, thereby driving up value…

At the end of 2022, there was an increase in the need to treat cold and flu symptoms. This was driven by the return of socialising following periods of social distancing, increased hand washing and the wearing of face masks throughout most of 2020…

Current value sales of cough, cold and allergy (hay fever) remedies rebounded to pre-pandemic levels in 2022 as the UK experienced its strongest cold and flu season in recent years, as a result of greater socialising as restrictions eased, thereby…